240
Participants
Start Date
October 31, 2012
Primary Completion Date
September 30, 2013
Study Completion Date
September 30, 2013
placebo
SC injections of placebo on days 1, 7, 14, 28 and 56
AllerT low dose
SC injections of AllerT 25-50 micrograms on days 1, 7, 14, 28 and 56
AllerT full dose
SC injections of AllerT 50-100 micrograms on days 1, 7, 14, 28 and 56
Paul Stradins Clinical University Hospital - Pulmonology Allergology, Riga
Center of examination and treatment of allergic diseases, Riga
Centre Hospitalier Universitaire Vaudois, Lausanne
Allergiklinikken, Hellerup
Viktorija Vevere private practice of Allergology, Rēzekne
Klinisk Institute, Odense
Lungemedicinsk Forskningsafdeling, Aarhus
Antakalnio affiliation of the Vilnius City Allergy Center, Vilnius
Alergotest, Lublin
University hospital Skane, Lund
Alergo-Med, Tarnów
NZOZ Przychodnia Lekarska Hipokrates, Zabrze
Kaunas Clinics University Hospital, Kaunas
CHU de Reims, Reims
Aler-med, Wroclaw
Hopitaux Universitaires de Strasbourg, Strasbourg
Orebro University Hospital, Örebro
Lungavdelningen, Vastmanlands, Västerås
SPZOZ Uniwersytecki Szpital Kliniczny - Allergology, Lodz
Alergologii Centrum, Lodz
Allergy Clinic JSC Perspektyvos, Vilnius
Vilnius University Hospital, Vilnius
Centrum Alergologii IRMED, Warsaw
Silesian Piasts University of Medicine in Wrocław, Wroclaw
Lead Sponsor
Anergis
INDUSTRY